Both goldthioglucose (GTG)-treated and the genetically obese (C57BL/6J ob/ob) mice were fed semisynthetic diets containing either soy protein isolate (SPI) or casein as a protein source, or laboratory chow. In GTG-induced obese mice, the plasma cholesterol level corre lated positively with their body weight. The level was highest in mice fed high-fat diet, and lowest in ones fed laboratory chow. No difference was observed between SPI and casein groups whether the diet was low-fat or high-fat. Thus, in the GTG-treated mice, SPI did not have a hypocho lesterolemic effect while dietary fat had a hypercholesterolemic effect, and laboratory chow contained some component(s) which can lower the plasma cholesterol level. Both neutral and acidic steroid contents in feces of the SPI group were not different from those of the casein group, and both groups of mice excreted a smaller amount of steroids than mice fed laboratory chow. Results of essentially the same tendency were obtained with normal mice regarding the effects of SPI and casein, although the degree of hypercholesterolemia was lower in high-fat-fed normal mice than in similarly fed GTG-treated mice. These results strengthened the inverse correlation between the amount of fecal steroids and the plasma cholesterol level upon feeding various proteins, indicating that the former is one of the important factors that determine the latter. The ob/ob mice showed a marked hypercholesterolemia irrespective of the kind of diet. The amount of fecal steroids was highest in the laboratory chow group and lowest in the casein group. This indicates that some factor(s) other than fecal steroid excretion is dominantly responsible for their hyper cholesterolemia.
Summary
Both goldthioglucose (GTG)-treated and the genetically obese (C57BL/6J ob/ob) mice were fed semisynthetic diets containing either soy protein isolate (SPI) or casein as a protein source, or laboratory chow. In GTG-induced obese mice, the plasma cholesterol level corre lated positively with their body weight. The level was highest in mice fed high-fat diet, and lowest in ones fed laboratory chow. No difference was observed between SPI and casein groups whether the diet was low-fat or high-fat. Thus, in the GTG-treated mice, SPI did not have a hypocho lesterolemic effect while dietary fat had a hypercholesterolemic effect, and laboratory chow contained some component(s) which can lower the plasma cholesterol level. Both neutral and acidic steroid contents in feces of the SPI group were not different from those of the casein group, and both groups of mice excreted a smaller amount of steroids than mice fed laboratory chow. Results of essentially the same tendency were obtained with normal mice regarding the effects of SPI and casein, although the degree of hypercholesterolemia was lower in high-fat-fed normal mice than in similarly fed GTG-treated mice. These results strengthened the inverse correlation between the amount of fecal steroids and the plasma cholesterol level upon feeding various proteins, indicating that the former is one of the important factors that determine the latter. The ob/ob mice showed a marked hypercholesterolemia irrespective of the kind of diet. The amount of fecal steroids was highest in the laboratory chow group and lowest in the casein group. This indicates that some factor(s) other than fecal steroid excretion is dominantly responsible for their hyper cholesterolemia.
Many investigators accept the view that the plasma cholesterol level correlates positively with body weight. Clinical observations, however, show that there are exceptions. Such a disagreement is probably due to the heterogeneities of human population, ages, causes of obesity, dietary habits and so on. We can obtain mice with various weight by a treatment with goldthioglucose (GTG), which induces an increase in body weight ranging from almost the same weight to about twice as heavy as the normal controls (1) . In the present experiment, we first examined the relationship between body weight and plasma cholesterol level in the GTG-induced obese mice under controlled conditions with respect to age, sex, diet, and living environment in order to know whether there exists a positive correlation between their body weights and plasma cholesterol levels.
Second, we examined the effect of dietary protein. It is known that dietary soy protein lowers the plasma cholesterol level compared with casein in experimental animals (2-7). By contrast, its hypocholesterolemic effect is not clear in humans (6, (8) (9) (10) (11) (12) . In general, the hypocholesterolemic effect of soy protein was observed in hyperlipidemic patients but not in normal subjects. Thus we were interested to know whether soy protein affected plasma cholesterol levels in the GTG-induced obese mice and also in the genetically obese (ob/ob) mice which are known to exhibit hypercholesterolemia.
Many works have been concerned with mechanism(s) by which dietary proteins affect plasma cholesterol levels (13) (14) (15) . Several lines of evidence suggest that fecal steroid excretion is one of the main factors that affect plasma cholesterol (5, (16) (17) (18) (19) (20) , and we have also presented results which support this suggestion (21) . In the present study, we further examined the relationship between plasma cho lesterol level and fecal steroid excretion in obese and normal mice. A part of the present results has been presented elsewhere (21) .
MATERIALS AND METHODS
Animals. Female mice of the ICR strain were obtained from CLEA Japan , (Tokyo), and fed standard laboratory chow (MF; Oriental Yeast, Tokyo). At the age of 4 weeks they were injected intraperitoneally with a freshly prepared aqueous solution of 0.5mg/g body weight of goldthioglucose (GTG; Sigma Chemical , USA), and fed laboratory chow. GTG-untreated mice were used as their controls . When they recovered from their reduced body weights caused by GTG treatment , that is, three to four days after the injection (1), the diet was switched to a semisynthetic high or low-fat diet containing either SPI or casein as a protein source without exogenous cholesterol as shown in Table 1 .
The genetically obese (C57BL/6J ob/ob) and their lean control mice were bred in our laboratory from a stock supplied kindly by Dr. M. Miyajima of the Animal Laboratory of Wakayama Medical College. Male and female mice were given low-fat diets for 7 weeks from 12 weeks of age.
All animals were usually group-housed in plastic cages with sawdust bedding , cholesterol level correlated positively with body weight. Correlation coefficients (r) between body weight and plasma cholesterol level of GTG-treated mice were 0.765 (p<0.001) in the high-fat group (Fig. 1 ( Fig. 2) , and 0.803 (p<0.001) in the chow-fed group (Fig. 3) . The gradient of regression line was largest in Fig. 1 and smallest in Fig. 3 . Figures 1 and 2 indicate that there was no significant difference between casein and SPI diets in both the high-fat and low-fat groups, and that the high-fat diets induced hypercholester olemia after a shorter feeding period than the low-fat diets. All of Figs. 1-3 suggest that laboratory chow had the ability of delaying the development of hypercholesterolemia induced by GTG treatment. This tendency is more clear in Table 3 , in which data were taken from the results with mice in Fig.  2 , their controls, and age-matched mice in Fig. 3 . The body weights were almost the same among GTG-treated groups, but the plasma cholesterol levels tended to be higher in both the low-fat groups than in the chow group. The plasma cholesterol levels of the obese mice weighing more than 41g, a value equal to the mean body weight plus the standard deviation of the chow group, were also higher, though not significant, in both of the low-fat groups than in the chow group. A few mice exhibited more than 100mg/100ml of plasma cholesterol levels in both of the low-fat groups, but not in the chow group.
Dietary effects on the plasma cholesterol level and fecal steroid excretion in GTG-treated and untreated normal mice are shown in Table 4 and Table 5 , respectively. In GTG-treated mice fed high-fat diets, the amount of fecal steroids was not different significantly between the casein and the SPI groups (Table 4) . On the other hand, normal mice fed SPI tended to excrete somewhat increased amount of steroids compared with mice fed casein whether they were fed high-fat or low-fat diets (Table 5 ). In both GTG-treated and normal mice, laboratory chow caused the largest excretion of steroids. Table 6 shows the plasma cholesterol levels and fecal steroid excretions in the ob/ob and lean control mice. All of the ob/ob mice showed a marked hypercho lesterolemia irrespective of diet. Obese mice fed SPI diet excreted a large amount of steroids compared with those fed casein, and lean mice fed SPI also showed a tendency to excrete a large amount of steroids compared with those fed casein though there was no significant difference between them. On the other hand, both the ob/ob and the lean mice fed laboratory chow excreted larger amounts of steroids than the casein or SPI group. No difference was shown in the corresponding dietary groups between the ob/ob and the lean mice.
DISCUSSION
A few works have been reported on blood cholesterol of GTG-treated mice . Zomzely and Mayer (24) reported that the plasma cholesterol level of GTG -induced obese mice was not different from that of normal mice. To the contrary , a significant increase was observed 16 weeks after GTG treatment, but not before 9 weeks (25) . In another report, hypercholesterolemia was observed 2 months after GTG treatment (26) . The present experiment showed that in GTG-treated mice the plasma cholesterol level increased in correlation with weight gain, and that high-fat diets induced hypercholesterolemia much earlier than low-fat diets. In addition, laboratory chow delayed the development of hypercholesterolemia even in comparison with low-fat diets. Thus, we conclude that the plasma cholesterol level is affected not only by the development of obesity but also by dietary factors. It has been reported that differences in protein contents of the diet result in different levels of plasma cholesterol (27) . However, the hypocholesterolemic effect of laboratory chow was not due to a protein content differing from the present semisynthetic diets: it contained almost the same energy percentage of protein (26.7%, according to the maker's catalog) as the semisynthetic low-fat diets.
In some species such as rabbit (2, 6) , rat (3, 6) , chicken (4), swine (5), and monkey (7), soy protein effectively lowered the plasma cholesterol level compared with casein. On the other hand, there are contradictory reports about the effect of the protein source on the plasma cholesterol level in mice. Soybean protein had no (28, 29) or a small effect (30) to lower the plasma cholesterol level compared with casein. Nagata et al. (31) have shown that in mice SPI had a noticeable hypo cholesterolemic effect at early stages of the feeding periods up to 20 weeks but not thereafter. In the present experiment, SPI had no hypocholesterolemic effect as compared with casein in mice which were treated with or without GTG and fed high-fat diets: hypercholesterolemia was produced by high-fat diets regardless of the protein source. In addition, casein did not increase the level of plasma cholesterol compared with SPI in mice fed a low-fat diet: the casein group showed almost the same low level as the SPI group in both GTG-treated (Fig. 2) normal (Table 4) mice. From experiments in rabbits (13, 16, 19) , swine (5), chicks (17) , and rats (18) , it has been suggested that increased fecal steroid excretion and reduced cholesterol absorption contribute to the decrease in the plasma cholesterol level in soy-fed animals compared with casein-fed ones. We obtained a similar result in rats (21) . In the present experiment with mice, the amount of fecal steroids was not much different, if any, between the SPI and the casein groups. This seemed to be responsible for the absence of difference in the plasma cholesterol level between the two groups. Thus, our results strengthened the inverse correlation between fecal steroid excretion and the plasma cholesterol level, indicating the importance of the former as a determinant factor of the latter.
In further contrast to rats, high-fat diets caused hypercholesterolemia, whereas the low-fat diets did not. The amount of fecal steroids was about the same between the two dietary groups. This indicates that dietary fat raises the plasma cholesterol level of mice by affecting some process other than the fecal steroid excretion.
In rabbits, rats, and chicks, steroid adsorptive ability of proteolytic interme diates derived from dietary proteins is known as an important factor for steroid excretion (17, 19, 30, (32) (33) (34) . It is likely, therefore, that digestion of casein and/or soy protein proceeds in somewhat different manners between rats and mice, so that the two proteins exert different effects on fecal steroid excretion in rats but not in mice. On the other hand, it is known that the dietary proteins modify the profile of microflora in the intestine (35, 36) . Since steroid excretion may be affected by microbial transformation of cholesterol and bile acids, a lack of difference in the profile of microflora between casein-and SPI-fed mice may be a part of the reason for the absence of difference in steroid excretion between the two dietary groups of mice.
A marked hypercholesterolemia was observed in the ob/ob mice irrespective of diets, including laboratory chow which produced high fecal steroid excretion. Accordingly, fecal steroid excretion is not a main factor to control the plasma cholesterol level in these mice. Operation of a powerful hypercholesterolemic mechanism(s), probably an increased synthesis of cholesterol, may be responsible for the hypercholesterolemia in this case. 
